APOA2 and neoplasm: In liver tumors, scRNA-seq analysis identified three pro-tumor TAN subsets (CCL4+ TANs, IFIT1+ TANs, and SPP1+ TANs) and one anti-tumor subset (APOA2+ TANs) [78].